Cargando…
EU Health Policy, Coherence, Stakeholder Diversity and Their Impact on the EMA
Innovation is a major pillar in bringing new, targeted medicines to patients. In the health arena, this means the translation of knowledge into what we can call “value.” The latter covers the value to patients but must also take into account value to healthcare systems, society and, of course, manuf...
Autores principales: | Horgan, Denis, Kent, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945918/ https://www.ncbi.nlm.nih.gov/pubmed/31988949 http://dx.doi.org/10.1159/000481301 |
Ejemplares similares
-
Personalising your health: an EU imperative
por: Horgan, Denis
Publicado: (2017) -
EU Policy on Lung Cancer CT Screening 2017
por: Field, John K., et al.
Publicado: (2017) -
Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021) -
The Diversity of Biosimilar Design and Development: Implications for Policies and Stakeholders
por: Grampp, Gustavo, et al.
Publicado: (2015) -
EMA : escala multidimensional de asertividad : manual /
por: Flores Galaz, Mirta Margarita
Publicado: (2004)